Form 8-K - Current report:
SEC Accession No. 0001193125-25-017314
Filing Date
2025-01-30
Accepted
2025-01-30 16:45:20
Documents
15
Period of Report
2025-01-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d776515d8k.htm   iXBRL 8-K 35020
2 EX-99.1 d776515dex991.htm EX-99.1 10992
6 GRAPHIC g776515g0130044131671.jpg GRAPHIC 2975
  Complete submission text file 0001193125-25-017314.txt   181611

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btmd-20250129.xsd EX-101.SCH 2832
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20250129_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20250129_pre.xml EX-101.PRE 11246
17 EXTRACTED XBRL INSTANCE DOCUMENT d776515d8k_htm.xml XML 3639
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 25574424
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)